StockData
Abbott Laboratories logo

Abbott Laboratories (ABT) operating KPIs

ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026Score 14/3036% above fair value
$106.20+1.63 (+1.56%)

Close on Oct 30, 2026Market cap $183.77BP/E 34.1Yield 2.26%

Abbott Laboratories medical Devices — Remaining Performance Obligations / Contract Backlog ($M) ($M)

Form 10-K / 10-Q Note (Revenue Recognition — Remaining Performance Obligations)

QuarterlyAnnual
Latest, Q2 2026
455
Period ended Jun 30, 2026
Change on a year earlier
+6.6%
427 in Q2 2025
History
27 quarters
Since Q4 2019
Sources
27
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedMedical Devices — Remaining Performance Obligations / Contract Backlog ($M) ($M)Year on yearSource
Q2 2026Jun 30, 2026455+6.6%SEC Filing (0001628280-26-050134) ↗
Q1 2026Mar 31, 2026429+1.4%SEC Filing (0001628280-26-028357) ↗
Q4 2025Dec 31, 2025444+0.9%SEC Filing (0001628280-26-010185) ↗
Q3 2025Sep 30, 2025436-6.4%SEC Filing (0001628280-25-047131) ↗
Q2 2025Jun 30, 2025427-13.4%SEC Filing (0001628280-25-036720) ↗
Q1 2025Mar 31, 2025423-14.5%SEC Filing (0001628280-25-021090) ↗
Q4 2024Dec 31, 2024440-7.9%SEC Filing (0001628280-25-007110) ↗
Q3 2024Sep 30, 2024466+2.2%SEC Filing (0001628280-24-044602) ↗
Q2 2024Jun 30, 2024493+3.8%SEC Filing (0001628280-24-033740) ↗
Q1 2024Mar 31, 2024495+10.0%SEC Filing (0001628280-24-020011) ↗
Q4 2023Dec 31, 2023478+10.6%SEC Filing (0001628280-24-005348) ↗
Q3 2023Sep 30, 2023456+5.3%SEC Filing (0001628280-23-035957) ↗
Q2 2023Jun 30, 2023475+8.9%SEC Filing (0001628280-23-027203) ↗
Q1 2023Mar 31, 2023450+5.1%SEC Filing (0001628280-23-015699) ↗
Q4 2022Dec 31, 2022432-0.7%SEC Filing (0001628280-23-004026) ↗
Q3 2022Sep 30, 2022433-2.7%SEC Filing (0001628280-22-027550) ↗

Cite this data

StockData. (2026). Abbott Laboratories Medical Devices — Remaining Performance Obligations / Contract Backlog ($M) ($M), quarterly Q4 2019–Q2 2026 [Data set]. Compiled from Abbott Laboratories SEC filings and investor materials. https://stockdatahq.com/stocks/abt/kpis/md-rpo

See every metric in the Abbott Laboratories KPI table. Data updated Oct 29, 2026.